Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation

被引:0
|
作者
Hamann, HA
Croyle, RT
Venne, VL
Baty, BJ
Smith, KR
Botkin, JR
机构
[1] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA
[2] NCI, NIH, Bethesda, MD 20892 USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[4] Univ Utah, Dept Pediat, Salt Lake City, UT USA
[5] Univ Utah, Dept Family & Consumer Studies, Salt Lake City, UT 84112 USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2000年 / 92卷 / 01期
关键词
ethics; patients' attitudes; BRCA1; testing; children;
D O I
10.1002/(SICI)1096-8628(20000501)92:1<25::AID-AJMG5>3.3.CO;2-P
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Advances in molecular biology and genetics have led to the identification of the breast/ ovarian cancer susceptibility genes BRCA1 and BRCA2, along with tests to detect mutations in these genes. Although the appropriateness of BRCA1/2 genetic testing for children has been debated in the literature, little is known about the attitudes of individuals who have undergone cancer susceptibility testing. The present study focused on attitudes toward BRCA1 testing for children among 218 adults from a Utah-based kindred who had received BRCA1 test results. Results indicated that approximately one-fourth of the participants would permit BRCA1 testing for children under the age of 18, General attitudes about genetic testing were predictive of attitudes toward the testing of children. In addition, men and individuals without a BRCA1 mutation were more likely to agree that miners should be allowed BRCA1 testing. Individuals whose mother had been affected with breast cancer were less likely to permit testing for miners. Among parents of minor children, less than one-fifth indicated that they would want BRCA1 testing for their own children; carrier status was not predictive of attitudes toward testing their own children. As breast/ovarian cancer susceptibility testing continues to be disseminated into clinical settings, there may be an increase in the number of test requests for miners. The findings of the present study represent an important step in exploring attitudes about genetic testing of children among individuals who have received cancer susceptibility test results. Am. J, Med. Genet, 92:25-32, 2000, (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 50 条
  • [41] Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians
    Dekanek, Erin W.
    Thull, Darcy L.
    Massart, Mylynda
    Grubs, Robin E.
    Rajkovic, Aleksander
    Mai, Phuong L.
    JOURNAL OF GENETIC COUNSELING, 2020, 29 (01) : 122 - 130
  • [42] Trends in reflex testing among Ashkenazi Jewish patients; Is BRCA1/2 founder mutation testing enough?
    Kopparam, R.
    Zhou, Z. N.
    Fields, J. C.
    Buskwofie, A.
    Caputo, T. A.
    Holcomb, M.
    Chapman-Davis, E.
    Frey, M. K.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 195 - 195
  • [43] Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample
    Schwartz, MD
    Peshkin, BN
    Hughes, C
    Main, D
    Isaacs, C
    Lerman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 514 - 520
  • [44] The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation
    Kinney, AY
    Bloor, LE
    Mandal, D
    Simonsen, SE
    Baty, BJ
    Holubkov, R
    Seggar, K
    Neuhausen, S
    Smith, K
    CANCER, 2005, 104 (11) : 2508 - 2516
  • [45] Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands
    Lodder, LN
    Frets, PG
    Trijsburg, RW
    Meijers-Heijboer, EJ
    Klijn, JGM
    Niermeijer, MF
    JOURNAL OF MEDICAL GENETICS, 2000, 37 (11) : 883 - 884
  • [46] BRCA1 and BRCA2 genetic testing in Hispanic patients:: Mutation prevalence and evaluation of the BRCAPRO risk assessment model
    Vogel, Kristen J.
    Atchley, Deann P.
    Erlichman, Julie
    Broglio, Kristine R.
    Ready, Kaylene J.
    Valero, Vicente
    Amos, Christopher I.
    Hortobagyi, Gabriel N.
    Lu, Karen H.
    Arun, Banu
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4635 - 4641
  • [47] Consumer issues related to life insurance and genetic testing: Preliminary findings for the BRCA1 gene mutation
    Smith, KR
    Zick, CD
    Mayer, RN
    Botkin, JR
    CONSUMER INTERESTS ANNUAL, VOL 43: 43RD ANNUAL CONFERENCE OF THE AMERICAN COUNCIL ON CONSUMER INTERESTS, 1997, : 203 - 204
  • [48] BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: Mutation spectrum and prevalence and analysis of mutation prediction models
    Capalbo, C.
    Ricevuto, E.
    Vestri, A.
    Ristori, E.
    Sidoni, T.
    Buffone, A.
    Adamo, B.
    Cortesi, E.
    Marchetti, P.
    Scambia, G.
    Tomao, S.
    Rinaldi, C.
    Zani, M.
    Ferraro, S.
    Frati, L.
    Screpanti, I.
    Gulino, A.
    Giannini, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII144 - VII144
  • [49] BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models
    Capalbo, C.
    Ricevuto, E.
    Vestri, A.
    Ristori, E.
    Sidoni, T.
    Buffone, O.
    Adamo, B.
    Cortesi, E.
    Marchetti, P.
    Scambia, G.
    Tomao, S.
    Rinaldi, C.
    Zani, M.
    Ferraro, S.
    Frati, L.
    Screpanti, I.
    Gulino, A.
    Giannini, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII34 - VII40
  • [50] Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study
    Jones, Tarsha
    McCarthy, Anne Marie
    Kim, Younji
    Armstrong, Katrina
    CANCER MEDICINE, 2017, 6 (07): : 1787 - 1798